Evaluation of 15 (S) 15 methyl-PGF 2 alpha methyl ester suppositories with a two dose schedule for termination of early pregnancy.
D000028:Abortion, Induced; D006063:Chorionic Gonadotropin / Q000097:blood; D003967:Diarrhea / Q000139:chemically induced; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D011374:Progesterone / Q000097:blood; D011460:Prostaglandins F / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D011465:Prostaglandins, Synthetic / Q000627:therapeutic use; D013488:Suppositories; D014621:Vagina; D014839:Vomiting / Q000139:chemically induced
D006063:Chorionic Gonadotropin; D011460:Prostaglandins F; D011465:Prostaglandins, Synthetic; D013488:Suppositories; D011374:Progesterone